Pipeline

Candidate Indication Discovery Preclinical Clinical
Phase 0 Phase I Phase II/III
FC313 Prostate Cancer (PSMA)
FC315 Prostate Cancer Therapy(PSMA)
FC211 Alzheimer’s Disease(Tau)
FLT Brain Tumor (Indication expansion)
FMT Brain Tumor
FC505 Stroke, MI
FC2 Hypoxia Tumor

Approved drugs

Candidate Indication
FDG Cancers
PDvue® Parkinson’s Disease
FLT Lung Cancer
Alzavue® Alzheimer’s Disease (β-amyloid)